News

Current news of SHS and our portfolio companies

31 March 2020 - Press Releases

Frankfurter Allgemeine Zeitung, page 18, by Ilka Kopplin: “New fund for medical technology – SHS Beteiligungsgesellschaft collects 150 million euros”

© All rights reserved. Frankfurter Allgemeine Zeitung GmbH, Frankfurt. Provided by the Frankfurter Allgemeine Archiv SHS partner Dr. André Zimmermann reports in an interview with the FAZ on the new medical technology fund of SHS, which like its successful predecessor fund aims to invest in innovative life science companies in German-speaking countries and now also […]

31 March 2020 - Press Releases

MedtechStrategist, Seite 58-59: “NUMARES HEALTH: Using Physics and Algorithms to Transform Clinical Diagnostics”

The article portrays the SHS portfolio company numares and provides insights into the company’s development and product portfolio. numares develops and sells diagnostic test systems and focuses on nuclear magnetic resonance (NMR) spectroscopy, machine learning and artificial intelligence.

31 March 2020 - Press Releases

Westdeutsche Allgemeine Zeitung: “Millions for a “spectacular idea” by a Bochum-based company”

The SHS portfolio company phenox, a strongly growing company in the field of neurointerventional stroke treatment, was portrayed by the WAZ. The company receives a grant of EUR 2.1 million from the Federal Ministry of Education and Research (BMBF) for its “anti-thrombosis” technology. This supports the development of coated implants for the treatment of brain […]

31 March 2020 - Press Releases

MassDevice: “CoreMedic launches first-in-human study of ChordArt mitral repair Device”

The start-up company CoreMedic has for the first time used its minimally invasive repair kits for the treatment of herniated valve diseases in a human operation. The operation was successful. SHS only acquired a stake in the company in 2017 with the aim of further developing the product.

31 March 2020 - Press Releases

medtech zwo: „Novo Klinik-Service takes over Innocath“

In mid-June the SHS portfolio company Novo announced the acquisition of Innocath. The Duisburg-based company specializes in the care of ventilated patients. Novo Klinik-Service, based in Bergheim, North Rhine-Westphalia, distributes medical equipment and medical technology solutions for intensive care, anaesthesia and nursing.

31 March 2020 - Press Releases

Börsen-Zeitung: “Jack Ma invests in Warngau”

The SHS portfolio company AMW, which specialises in drug delivery systems, will be acquired by the investment company of Alibaba founder Jack Ma and the Chinese drug developer Hybio Pharmaceutical. SHS has held an interest in AMW since its foundation in 2008, along with other shareholders.

31 March 2020 - Portfolio News

medigroba aid supply now also in Hessen

medigroba GmbH, with its headquarters in Balingen, continues to expand and has now also gained a foothold in Hesse following the expansion of the site in North Rhine-Westphalia, where people in need of care have been provided with medical aids since 2019. To support the regional sales team with prompt deliveries, a new location has […]

19 March 2020 - Press Releases

Venture Capital Journal: “SHS Fund V giving digital health a financial shot in the arm”

Digitization in the healthcare industry is progressing only very slowly due to the high density of regulation and complex development procedures. SHS will now invest its fifth fund (planned volume: EUR 150 million) in digital health companies for the first time. SHS Managing Partner Hubertus Leonhardt outlines the particular difficulties involved in investing in medical […]

19 March 2020 - Press Releases

Unquote: DACH – “Concerning prognoses for German healthcare”

The private equity news portal Unquote evaluates the effects of the new German Scheduling and Supply Act and refers to the opportunities and risks of the global medical technology market. Despite tougher regulations, experts do not expect an economic slowdown for the medical technology, life science and biotechnology industries. Dr. Andre Zimmermann, Partner at SHS […]

19 March 2020 - Press Releases

VC-Magazin: „Losgelöst von jeglichen Basiskenngrößen“

The Venture Capital magazine examines the price level of buyout transactions this spring, with a special focus on medical technology. Experts classify the industry as very promising, but rate the prices as often not justified. Hubertus Leonhardt, Managing Partner at SHS Gesellschaft für Beteiligungsmanagement mbH, points out that buyout transactions are often about more than […]